The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Kristen Brianne Kluska - Cantor Fitzgerald & Co., Research Division - Analyst
: First, wishing Stu the best in his retirement, and he should feel very proud of all the patients who benefited from what PTC has created. And Matt,
wishing you the best in your new role. Congratulations on the promotion. So Matt, I wanted to ask, I think you brought a really unique perspective
coming from the COO role as you were very engaged with not just the investor community, but also the medical community and made it a priority
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
Question: Colin Nigel Bristow - UBS Investment Bank, Research Division - Analyst
: Matt, congratulations on the role and all the best to Stu on such an incredible career of achievements. Matt, now you're in this seat. I presume at
some level, you'll take a look at the pipeline, business development goals, et cetera, with a sort of fresh set of eyes. Is there a time period you have
in mind in terms of this sort of review of the company from the new seat and then potentially enacting any subsequent change?
Matthew Klein
Thank you very much for the question and for the congratulations. As I mentioned earlier, the leadership team of PTC is stable. It remains intact.
It's the same team that has helped formulate our strategy both in terms of internal commercial and pipeline planning as well as how we've been
thinking about business development. And that will largely remain unchanged. Obviously, as you point out, taking over the CEO helm puts me in
a position to maybe have a slightly different perspective on this. And my plan is to continue to work with our leadership team. And as we always
do, continue to revisit our pipeline, review our portfolio and review our strategies. That's the natural thing that we do as part of responsible and
thoughtful corporate leadership. And of course, as we're doing that, and we think about making adjustments that are appropriate at the right time,
we'll, of course, share that with all of you through our earnings discussions as well as other opportunities.
|
